M. Cottagnoud

698 total citations
24 papers, 556 citations indexed

About

M. Cottagnoud is a scholar working on Epidemiology, Pharmacology and Microbiology. According to data from OpenAlex, M. Cottagnoud has authored 24 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Pharmacology and 18 papers in Microbiology. Recurrent topics in M. Cottagnoud's work include Pneumonia and Respiratory Infections (22 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Bacterial Infections and Vaccines (18 papers). M. Cottagnoud is often cited by papers focused on Pneumonia and Respiratory Infections (22 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Bacterial Infections and Vaccines (18 papers). M. Cottagnoud collaborates with scholars based in Switzerland, United States and United Kingdom. M. Cottagnoud's co-authors include Philippe Cottagnoud, P. Cottagnoud, Armin Stucki, F. Acosta, Martin G. Täuber, A. Stucki, M G Täuber, Marc Pfister, Lukas Flatz and K Neftel and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. Cottagnoud

24 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Cottagnoud Switzerland	16	366	301	229	170	119	24	556
P. Cottagnoud Switzerland	13	215 0.6×	180 0.6×	117 0.5×	89 0.5×	77 0.6×	22	388
Linda M. Kelly United States	13	320 0.9×	77 0.3×	251 1.1×	160 0.9×	179 1.5×	17	494
S Ozeki Japan	10	127 0.3×	176 0.6×	128 0.6×	59 0.3×	218 1.8×	16	443
Renée S. Blosser-Middleton United States	14	277 0.8×	86 0.3×	164 0.7×	119 0.7×	167 1.4×	17	460
Y. Yang China	14	323 0.9×	152 0.5×	25 0.1×	133 0.8×	69 0.6×	28	566
R R Packer United States	11	187 0.5×	51 0.2×	208 0.9×	119 0.7×	189 1.6×	22	418
Irene Yu Lubenko United States	10	155 0.4×	46 0.2×	356 1.6×	225 1.3×	296 2.5×	20	538
Laurie Kilburn Canada	6	204 0.6×	35 0.1×	160 0.7×	139 0.8×	87 0.7×	7	454
J. Scott Overcash United States	11	194 0.5×	39 0.1×	174 0.8×	373 2.2×	175 1.5×	25	722
David Styers United States	6	92 0.3×	70 0.2×	45 0.2×	236 1.4×	57 0.5×	8	460

Countries citing papers authored by M. Cottagnoud

Since Specialization

Citations

This map shows the geographic impact of M. Cottagnoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cottagnoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cottagnoud more than expected).

Fields of papers citing papers by M. Cottagnoud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cottagnoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cottagnoud. The network helps show where M. Cottagnoud may publish in the future.

Co-authorship network of co-authors of M. Cottagnoud

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cottagnoud. A scholar is included among the top collaborators of M. Cottagnoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cottagnoud. M. Cottagnoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cottagnoud, P., M. Cottagnoud, F. Acosta, & A. Stucki. (2013). Efficacy of Ceftaroline Fosamil against Penicillin-Sensitive and -Resistant Streptococcus pneumoniae in an Experimental Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 57(10). 4653–4655. 17 indexed citations

Stucki, A., F. Acosta, M. Cottagnoud, & P. Cottagnoud. (2013). Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae Strains in a Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 57(12). 5808–5810. 19 indexed citations

Stucki, A., et al.. (2011). Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis. Journal of Antimicrobial Chemotherapy. 67(3). 661–665. 3 indexed citations

Stucki, A., et al.. (2011). Evaluation of Ceftobiprole Activity against a Variety of Gram-Negative Pathogens, Including Escherichia coli, Haemophilus influenzae (β-Lactamase Positive and β-Lactamase Negative), and Klebsiella pneumoniae, in a Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 56(2). 921–925. 15 indexed citations

Stucki, A., Peter Arne Gerber, F. Acosta, et al.. (2008). Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model. Journal of Antimicrobial Chemotherapy. 61(3). 665–669. 9 indexed citations

Stucki, A., et al.. (2007). Daptomycin Produces an Enhanced Bactericidal Activity Compared to Ceftriaxone, Measured by [ ³ H]Choline Release in the Cerebrospinal Fluid, in Experimental Meningitis Due to a Penicillin-Resistant Pneumococcal Strain without Lysing Its Cell Wall. Antimicrobial Agents and Chemotherapy. 51(6). 2249–2252. 31 indexed citations

Stucki, Armin, et al.. (2006). Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. Journal of Antimicrobial Chemotherapy. 57(4). 720–723. 62 indexed citations

Stucki, Armin, et al.. (2006). Efficacy of Telavancin against Penicillin-Resistant Pneumococci and Staphylococcus aureus in a Rabbit Meningitis Model and Determination of Kinetic Parameters. Antimicrobial Agents and Chemotherapy. 50(2). 770–773. 36 indexed citations

Cottagnoud, Philippe, et al.. (2005). Preincubation of Pneumococci with β-Lactams Alone or Combined with Levofloxacin Prevents Quinolone-Induced Resistance without Increasing Intracellular Levels of Levofloxacin. Antimicrobial Agents and Chemotherapy. 49(8). 3517–3519. 1 indexed citations

10.

Cottagnoud, M., et al.. (2003). Meropenem Prevents Levofloxacin-Induced Resistance in Penicillin-Resistant Pneumococci and Acts Synergistically with Levofloxacin in Experimental Meningitis. European Journal of Clinical Microbiology & Infectious Diseases. 22(11). 656–662. 17 indexed citations

11.

Cottagnoud, P., Paul Majcherczyk, F. Acosta, et al.. (2003). The Stereochemistry of the Amino Acid Side Chain Influences the Inflammatory Potential of Muramyl Dipeptide in Experimental Meningitis. Infection and Immunity. 71(6). 3663–3666. 7 indexed citations

12.

Kuhn, Félix P., M. Cottagnoud, F. Acosta, et al.. (2003). Cefotaxime Acts Synergistically with Levofloxacin in Experimental Meningitis Due to Penicillin-Resistant Pneumococci and Prevents Selection of Levofloxacin-Resistant Mutants In Vitro. Antimicrobial Agents and Chemotherapy. 47(8). 2487–2491. 18 indexed citations

13.

Cottagnoud, P., M. Cottagnoud, & M G Täuber. (2002). Vancomycin Acts Synergistically with Gentamicin against Penicillin-Resistant Pneumococci by Increasing the Intracellular Penetration of Gentamicin. Antimicrobial Agents and Chemotherapy. 47(1). 144–147. 33 indexed citations

14.

Cottagnoud, Philippe, et al.. (2002). Gemifloxacin Is Efficacious against Penicillin-Resistant and Quinolone-Resistant Pneumococci in Experimental Meningitis. Antimicrobial Agents and Chemotherapy. 46(5). 1607–1609. 16 indexed citations

15.

Cottagnoud, Philippe, et al.. (2002). Gentamicin Increases the Efficacy of Vancomycin against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 46(1). 188–190. 16 indexed citations

16.

Perrig, Martin, et al.. (2001). Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. Journal of Antimicrobial Chemotherapy. 47(5). 701–704. 15 indexed citations

17.

Cottagnoud, Philippe, José M. Entenza, M. Cottagnoud, et al.. (2001). Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiology. 1(1). 9–9. 13 indexed citations

18.

Cottagnoud, Philippe, et al.. (2000). Synergy between Trovafloxacin and Ceftriaxone against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model and In Vitro. Antimicrobial Agents and Chemotherapy. 44(8). 2179–2181. 27 indexed citations

19.

Cottagnoud, M., et al.. (1999). Meropenem Alone and in Combination with Vancomycin in Experimental Meningitis Caused by a Penicillin-Resistant Pneumococcal Strain. European Journal of Clinical Microbiology & Infectious Diseases. 18(12). 866–870. 28 indexed citations

20.

Cottagnoud, M., et al.. (1999). Trovafloxacin in Combination with Vancomycin against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 43(4). 963–965. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact